New Two-Drug combo battles advanced colon cancer
NCT ID NCT04895722
Summary
This study is testing whether a new two-drug combination (MK-1308A) works better than other treatments for people with advanced colorectal cancer that has spread and has specific genetic features (MSI-H/dMMR). The trial involves 302 participants who either haven't received treatment yet or whose cancer has progressed after standard treatments. Researchers will measure how well the tumors shrink and how long the treatment keeps the cancer under control.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AZ Delta vzw ( Site 0106)
Roeselare, West-Vlaanderen, 8800, Belgium
-
Aalborg Universitetshospital, Syd ( Site 1903)
Aalborg, North Denmark, 9000, Denmark
-
Alexandra General Hospital of Athens-ONCOLOGY DEPT. ( Site 2704)
Athens, Attica, 115 28, Greece
-
Ankara City Hospital-Medical Oncology ( Site 1306)
Ankara, 06800, Turkey (Türkiye)
-
Asan Medical Center-Department of Oncology ( Site 1105)
Seoul, 05505, South Korea
-
Asklepios Altona-Oncology ( Site 0602)
Hamburg, 22763, Germany
-
Assistance Publique Hôpitaux de Marseille - Hôpital de la Ti-Service d'Hepato-Gastro-Enterologie et
Marseille, Bouches-du-Rhone, 13385, France
-
Bacs-Kiskun Megyei Korhaz-Onkoradiologiai Kozpont ( Site 2005)
Kecskemét, Bács-Kiskun county, 6000, Hungary
-
Baskent University Dr. Turgut Noyan Research and Training Center ( Site 1303)
Adana, 01250, Turkey (Türkiye)
-
Baylor Scott & White Medical Center - Temple-Division of Hematology/Oncology ( Site 1549)
Temple, Texas, 76508, United States
-
Beatson West of Scotland Cancer Centre-Clinical Trials Unit ( Site 1401)
Glasgow, Glasgow City, G12 0YN, United Kingdom
-
CELAN,S.A ( Site 2202)
Guatemala City, 01010, Guatemala
-
CHU Rangueil-Digestive oncology department ( Site 0502)
Toulouse, Haute-Garonne, 31059, France
-
CIMCA-Hemato-Oncology ( Site 2101)
San José, Provincia de San José, 1000, Costa Rica
-
COMPLEJO HOSPITALARIO DE NAVARRA-oncologia médica ( Site 1210)
Pamplona, Navarre, 31009, Spain
-
Cardiomed SRL Cluj-Napoca ( Site 2602)
Cluj-Napoca, Cluj, 400015, Romania
-
Centre Georges François Leclerc ( Site 0506)
Dijon, Cote-d Or, 21079, France
-
Centre Hospitalier Universitaire de Poitiers ( Site 0511)
Poitiers, Vienne, 86021, France
-
Centro Medico Integral De Cancerología (CEMIC) ( Site 2203)
Quetzaltenango, 09002, Guatemala
-
Centro Regional de Sub Especialidades Médicas SA ( Site 2204)
Quetzaltenango, 09001, Guatemala
-
Centrul de Oncologie "Sfântul Nectarie"-Medical Oncology ( Site 2604)
Craiova, Dolj, 200542, Romania
-
Charité Universitaetsmedizin Berlin - Campus Mitte ( Site 0604)
Berlin, 10117, Germany
-
Clinica Colsanitas S.A, Sede Clínica Universitaria Colombia ( Site 1611)
Bogotá, Bogota D.C., 111321, Colombia
-
Clinica de la Costa S.A.S. ( Site 1608)
Barranquilla, Atlántico, 080020, Colombia
-
Cliniques universitaires Saint-Luc-Medical Oncology ( Site 0104)
Brussels, Bruxelles-Capitale, Region de, 1200, Belgium
-
DOLNOSLASKIE CENTRUM ONKOLOGII PULMONOLOGII I HEMATOLOGII ( Site 0920)
Wroclaw, Lower Silesian Voivodeship, 53-413, Poland
-
Debreceni Egyetem Klinikai Kozpont-Onkológiai Klinika ( Site 2008)
Debrecen, 4032, Hungary
-
European Interbalkan Medical Center-Oncology Department ( Site 2701)
Thessaloniki, 57001, Greece
-
Evgenidion Hospital ( Site 2702)
Athens, Attica, 115 28, Greece
-
Fed State Budgetary Inst N.N. Blokhin Med Center of Oncology-Clinical Pharmacology and Chemotherapy
Moscow, Moscow, 115478, Russia
-
First Moscow State Medical University I.M. Sechenov-Interhospital Institution Health Management Cl
Moscow, Moscow, 119991, Russia
-
Fondazione IRCCS Istituto Nazionale dei Tumori-Struttura Complessa Oncologia Medica 1 ( Site 0802)
Milan, Lombardy, 20133, Italy
-
Fundación Colombiana de Cancerología Clínica Vida ( Site 1606)
Medellín, Antioquia, 050030, Colombia
-
Fundación Instituto Valenciano de Oncología ( Site 1209)
Valencia, Valenciana, Comunitat, 46009, Spain
-
Fundeni Clinical Institute-Medical Oncology ( Site 2603)
Bucharest, București, 022328, Romania
-
GBUZ SPb CRPCstmc(o) ( Site 1005)
Saint Petersburg, Sankt-Peterburg, 197758, Russia
-
H.R.U Malaga - Hospital General ( Site 1207)
Málaga, Malaga, 29010, Spain
-
HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑON ( Site 1206)
Madrid, Madrid, Comunidad de, 28007, Spain
-
Hacettepe Universitesi-oncology hospital ( Site 1301)
Ankara, 06230, Turkey (Türkiye)
-
Hematology Oncology Associates of Rockland ( Site 1525)
Nyack, New York, 10960, United States
-
Hopital Claude Huriez - CHU de Lille ( Site 0510)
Lille, Nord, 59037, France
-
Hospital Clinico San Carlos-Oncology Department ( Site 1204)
Madrid, 28040, Spain
-
Hospital Metropolitano - Sede Lindora-Metropolitano Research Institute Sede Lindora ( Site 2102)
Santa Ana, Provincia de San José, 10903, Costa Rica
-
Hospital Universitari Vall d'Hebron ( Site 1201)
Barcelona, Catalonia, 08035, Spain
-
Hospital Universitario Central de Asturias-Medical Oncology ( Site 1203)
Oviedo, Principality of Asturias, 33011, Spain
-
Hospital Universitario Marqués de Valdecilla ( Site 1202)
Santander, Cantabria, 39008, Spain
-
Hospital of Lithuanian University of Health Sciences Kauno klinikos ( Site 2402)
Kaunas, Kaunas County, 50161, Lithuania
-
Hôpital Saint Antoine-Oncologie médicale ( Site 0508)
Paris, 75571, France
-
INTEGRA Cancer Institute-Oncology ( Site 2201)
Guatemala City, 01010, Guatemala
-
Icahn School of Medicine at Mount Sinai ( Site 1528)
New York, New York, 10029, United States
-
Instituto de Cancerología ( Site 1610)
Medellín, Antioquia, 050025, Colombia
-
Istanbul Universitesi Cerrahpasa-Medical Oncology ( Site 1302)
Istanbul, 34668, Turkey (Türkiye)
-
Istituto Nazionale Tumori IRCCS Fondazione Pascale-Department of Abdominal Oncology ( Site 0803)
Naples, 80131, Italy
-
Istituto Oncologico Veneto IRCCS ( Site 0804)
Padua, 35128, Italy
-
Jász-Nagykun-Szolnok Megyei Hetényi Géza Kórház-Onkologiai Kozpont ( Site 2001)
Szolnok, Jász-Nagykun-Szolnok, 5000, Hungary
-
Kliniken Essen-Mitte, Evangelische Huyssens-Stiftung ( Site 0611)
Essen, North Rhine-Westphalia, 45136, Germany
-
Korea University Anam Hospital ( Site 1107)
Seoul, 02841, South Korea
-
Kyungpook National University Chilgok Hospital-Hematology/oncology ( Site 1103)
Daegu, Taegu-Kwangyokshi, 41404, South Korea
-
Luxmed Onkologia sp. z o. o. ( Site 0915)
Warsaw, Masovian Voivodeship, 01-748, Poland
-
MEDI-K CAYALA ( Site 2205)
Guatemala City, 01016, Guatemala
-
McGill University Health Centre-CIM - Oncology ( Site 0306)
Montreal, Quebec, H4A 3J1, Canada
-
Mediservis del Tolima IPS S.A.S ( Site 1609)
Ibagué, Tolima Department, 730006, Colombia
-
Mid Florida Cancer Center ( Site 1519)
Orange City, Florida, 32763, United States
-
Mrukmed-Mrukmed ( Site 0901)
Rzeszów, Podkarpackie Voivodeship, 35-021, Poland
-
Muenchen Klinik Neuperlach, Klinik fuer Haematologie und Onkologie ( Site 0612)
Munich, Bavaria, 81737, Germany
-
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Onkologii i Radioterapii ( Site
Warsaw, Masovian Voivodeship, 02-034, Poland
-
National Cancer Institute ( Site 2401)
Vilnius, Vilniaus Miestas, 08660, Lithuania
-
Nederlands Kanker Instituut - Antoni van Leeuwenhoek (NKI-AVL) ( Site 2901)
Amsterdam, North Holland, 1066CX, Netherlands
-
North Estonia Medical Centre Foundation-Chemotherapy ( Site 2301)
Tallinn, Harju, 13419, Estonia
-
Northwest Medical Specialties, PLLC ( Site 1546)
Tacoma, Washington, 98405, United States
-
Odense Universitetshospital ( Site 1902)
Odense, Region Syddanmark, 5000, Denmark
-
Oncomédica S.A.S ( Site 1602)
Montería, Departamento de Córdoba, 230002, Colombia
-
Otto-von-Guericke-Universität Magdeburg-Klinik für Gastroenterologie, Hepatologie und Infektiologie
Magdeburg, Saxony-Anhalt, 39120, Germany
-
Powiatowe Centrum Zdrowia ( Site 0911)
Brzeziny, Łódź Voivodeship, 95-060, Poland
-
Pécsi Tudományegyetem Klinikai Központ-Onkoterápiás Intézet ( Site 2009)
Pécs, Baranya, 7624, Hungary
-
Regionshospitalet Gødstrup ( Site 1901)
Herning, Central Jutland, 7400, Denmark
-
Republican Clinical Oncology Dispensary-Chemotherapy #3 ( Site 1006)
Kazan', Tatarstan, Respublika, 420029, Russia
-
Rigshospitalet ( Site 1904)
Copenhagen, Capital Region, 2100, Denmark
-
Rostov Cancer Research Institute ( Site 1014)
Rostov-on-Don, Rostov Oblast, 344037, Russia
-
Saint-Petersburg City Clinical Oncology Dispensary-Department of chemotherapy ( Site 1001)
Saint Petersburg, Leningradskaya Oblast', 198255, Russia
-
Samsung Medical Center-Division of Hematology/Oncology ( Site 1102)
Seoul, 06351, South Korea
-
Semmelweis Egyetem-Belgyógyászati és Hematológiai Klinika ( Site 2002)
Budapest, 1088, Hungary
-
Seoul National University Hospital-Internal Medicine ( Site 1101)
Seoul, 03080, South Korea
-
Severance Hospital, Yonsei University Health System-Medical oncology ( Site 1104)
Seoul, 03722, South Korea
-
Sociedad De Oncologia Y Hematologia Del Cesar-Oncology ( Site 1601)
Valledupar, Cesar Department, 200001, Colombia
-
Somogy Megyei Kaposi Mór Oktató Kórház-Oncology center ( Site 2010)
Kaposvár, Somogy County, 7400, Hungary
-
Spitalul de Oncologie Monza Oncologie Medicala ( Site 2601)
Bucharest, București, 013812, Romania
-
Sunnybrook Research Institute - Odette Cancer Centre ( Site 0316)
Toronto, Ontario, M4N 3M5, Canada
-
Szpital Wojewódzki im. Mikoaja Kopernika w Koszalinie-Oddzial Dzienny Chemioterapii ( Site 0903)
Koszalin, West Pomeranian Voivodeship, 75-581, Poland
-
TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi-oncology ( Site 1305)
Istanbul, 34722, Turkey (Türkiye)
-
Tartu University Hospital ( Site 2302)
Tartu, Tartu, 50406, Estonia
-
The Catholic Univ. of Korea Seoul St. Mary's Hospital-Medical Oncology ( Site 1106)
Seoul, 06591, South Korea
-
The Moncton Hospital-Oncology ( Site 0307)
Moncton, New Brunswick, E1C 6Z8, Canada
-
The West Clinic, PLLC dba West Cancer Center ( Site 1576)
Germantown, Tennessee, 38138, United States
-
UCLH-Cancer Clinical Trials Unit ( Site 1402)
London-Camden, London, City of, NW1 2PG, United Kingdom
-
UPMC Hillman Cancer Center ( Site 1516)
Pittsburgh, Pennsylvania, 15232, United States
-
UT Southwestern Medical Center ( Site 1551)
Dallas, Texas, 75390, United States
-
UZ Brussel ( Site 0105)
Brussels, Bruxelles-Capitale, Region de, 1090, Belgium
-
UZ Leuven ( Site 0101)
Leuven, Vlaams-Brabant, 3000, Belgium
-
Universitaetsklinikum Carl Gustav Carus Dresden-Medical Dept I - Medical Oncology ( Site 0601)
Dresden, Saxony, 01307, Germany
-
University Cancer & Blood Center, LLC ( Site 1521)
Athens, Georgia, 30607, United States
-
University General Hospital of Heraklion-Internal Medicine-Oncology ( Site 2703)
Heraklion, Irakleio, 715 00, Greece
-
University Hospital Coventry & Warwickshire ( Site 1406)
Coventry, CV2 2DX, United Kingdom
-
University of Chicago Medical Center-Medicine - Section of Hematology/Oncology - Gastrointestinal P
Chicago, Illinois, 60637, United States
-
Universitätsklinikum Marburg ( Site 0610)
Marburg, Hesse, 35043, Germany
-
Université Catholique de Louvain-Namur - Centre Hospitalier -Oncology ( Site 0102)
Yvoir, Namur, 5530, Belgium
-
VILNIUS UNIVERSITY HOSPITAL SANTAROS KLINIKOS ( Site 2403)
Vilnius, 08460, Lithuania
-
Vanderbilt University Medical Center-Vanderbilt-Ingram Cancer Center ( Site 1509)
Nashville, Tennessee, 37232, United States
-
Velindre Cancer Centre-Research and Development ( Site 1415)
Cardiff, CF14 2TL, United Kingdom
Conditions
Explore the condition pages connected to this study.